Lysogene Pushes Forward With Sanfilippo Syndrome Study, Establishes Footprint in U.S. Post author:Sam Post published:October 24, 2017 Post category:BioPharma Finding a treatment for Sanfilippo Syndrome is a personal matter for the Lysogene team. Source: BioSpace You Might Also Like Massachusetts' Exosome Diagnostics Snags $30 Million July 24, 2017 CARsgen Therapeutics Joins The Alliance For Regenerative Medicine June 29, 2017 AMO Pharma Sees Positive Results in Phase II Trials March 15, 2018
